We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Upstart Holdings
UPST
$3.08B
| $2.7M | ﹤0.01% |
105,393
-4,243
| -4% | -$149K |
|
952
Liberty Media Series C
FWONK
$24.1B
| $2.68M | ﹤0.01% |
31,617
+321
| +1% | +$28.1K |
|
953
Pacira BioSciences
PCRX
$1B
| $2.66M | ﹤0.01% |
117,894
+99
| +0.1% | +$2.2K |
|
954
Sally Beauty Holdings
SBH
$1.6B
| $2.65M | ﹤0.01% |
191,088
-800
| -0.4% | -$12.2K |
|
955
Fortuna Silver Mines
FSM
$2.92B
| $2.64M | ﹤0.01% |
266,015
+13,482
| +5% | +$146K |
|
956
Match Group
MTCH
$8.89B
| $2.62M | ﹤0.01% |
85,292
-7,504
| -8% | -$234K |
|
957
Masco
MAS
$15.2B
| $2.62M | ﹤0.01% |
43,379
+22,850
| +111% | +$1.55M |
|
958
Ingevity
NGVT
$2.58B
| $2.58M | ﹤0.01% |
36,227
-6,069
| -14% | -$415K |
|
959
TransUnion
TRU
$15.4B
| $2.58M | ﹤0.01% |
37,597
-2,818
| -7% | -$216K |
|
960
Invitation Homes
INVH
$18.1B
| $2.57M | ﹤0.01% |
103,393
-5,472
| -5% | -$143K |
|
961
Kohl's
KSS
$2.28B
| $2.56M | ﹤0.01% |
198,661
-25,235
| -11% | -$425K |
|
962
Pediatrix Medical
MD
$2.12B
| $2.56M | ﹤0.01% |
119,668
+493
| +0.4% | +$10.3K |
|
963
Disc Medicine
IRON
$2.98B
| $2.55M | ﹤0.01% |
39,910
-293
| -0.7% | -$20.3K |
|
964
Kanzhun
BZ
$7.35B
| $2.55M | ﹤0.01% |
190,419
-11,522
| -6% | -$195K |
|
965
RPM International
RPM
$14.7B
| $2.54M | ﹤0.01% |
25,560
-2,027
| -7% | -$219K |
|
|
GTM
966
ZoomInfo Technologies
GTM
$1.09B
| $2.53M | ﹤0.01% |
423,234
-42,548
| -9% | -$313K |
|
967
Teck Resources
TECK
$32.4B
| $2.53M | ﹤0.01% |
48,798
+34,454
| +240% | +$1.84M |
|
968
OSI Systems
OSIS
$3.86B
| $2.53M | ﹤0.01% |
9,519
+5,873
| +161% | +$1.62M |
|
969
Lifestance Health
LFST
$4.01B
| $2.51M | ﹤0.01% |
394,010
+13,759
| +4% | +$95.7K |
|
970
AeroVironment
AVAV
$8.58B
| $2.48M | ﹤0.01% |
13,574
+5,309
| +64% | +$1.4M |
|
971
BCE
BCE
$20.4B
| $2.48M | ﹤0.01% |
98,263
+47,622
| +94% | +$1.21M |
|
972
MasTec
MTZ
$22B
| $2.48M | ﹤0.01% |
7,693
-743
| -9% | -$201K |
|
973
Dycom Industries
DY
$12.4B
| $2.47M | ﹤0.01% |
7,289
-1,107
| -13% | -$416K |
|
974
RB Global
RBA
$17.7B
| $2.43M | ﹤0.01% |
25,391
+21,552
| +561% | +$2.28M |
|
975
Pebblebrook Hotel Trust
PEB
$2.17B
| $2.43M | ﹤0.01% |
192,375
-713,075
| -79% | -$8.74M |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.